Durability Extension Study to Assess Clinical Activity and Safety of Enobosarm (GTx-024) in Stress Urinary Incontinence

NCT03508648 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Lack of efficacy from primary study

Conditions

Stress Urinary Incontinence

Interventions

DRUG: GTx-024
DRUG: Matching Placebo

Sponsor

GTx